Aug 31, 2024, 18:34
Erman Akkus: First line treatment of metastatic Colorectal Cancer in older patients
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared on X:
“FOLFOX/Xelox + beva vs. 5FU/cape +beva in first line treatment of metastatic CRC in older patients.
Median age 80 and 79
•No difference in PFS, 10 vs 9.4 mo.
•No difference in OS, 19.7 vs 21.3 mo.
•grade ≥3 AEs 69% vs. 52%
~65% left sided and ~36% RAS WT.”
Source: Erman Akkus/X
For more posts by Erman Akkus, visit oncodaily.com
Atsuo Takashima
cancer
Erman Akkus
Fumio Nagashima
Haruhiko Fukuda
Hideo Baba
Hiroshi Katayama
Hitoshi Ojima
Jun Watanabe
Junki Mizusawa
Katsunori Shinozaki
Ken Nakata
Kenichi Nakamura
Masahiko Ando
Masako Asayama
OncoDaily
Oncology
Seiji Hasegawa
Shunsuke Tsukamoto
Tadamichi Denda
Tetsuya Hamaguchi
Toshiki Masuishi
Yasuhiro Shimada
Yukihide Kanemitsu
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48